搜索临床试验以:Pharmacokinetics (PK)
总计11993个结果
-
Shanxi Kangbao Biological Product Co., Ltd.Institute of Pathogen Biology, Chinese Academy of Medical Sciences招聘中
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany完全的
-
Luye Pharma Group Ltd.主动,不招人
-
Universitas PadjadjaranRadboud University Medical Center完全的
-
Kent State UniversityUniversity of Pennsylvania; Case Western Reserve University未知
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven完全的
-
AstraZeneca完全的
-
AstraZenecaPPD; Parexel; Covance; Iqvia Pty Ltd完全的
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 III 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 预后 IIIB 期乳腺癌 AJCC v8 | 预后性 IIIC 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 胰腺导管腺癌 | 晚期恶性实体瘤 | 难治性淋巴瘤 | II 期胰腺癌 AJCC v8 | III 期胰腺癌 AJCC v8 | IV 期胰腺癌 AJCC v8 | 复发性淋巴瘤 | 转移性恶性实体瘤 | 雌激素受体阴性 | HER2/Neu... 及其他条件美国
-
Meridian Bioscience, Inc.Rabin Medical Center完全的
-
Liverpool Women's NHS Foundation TrustUniversity of Liverpool完全的
-
Asan Medical Center完全的
-
Chiesi Farmaceutici S.p.A.完全的
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New Zealand终止
-
PENTA Foundation完全的